SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (5465)9/4/1998 10:09:00 AM
From: Platter  Read Replies (2) of 7041
 
With FDA approval of Vasomax(being the first to compete with Viagra) expected soon....Look for heavy short covering in the next 2 weeks....Last earning report on 8/10/98, revenues increased from 847000 to 6.7 million in the last quarter....Very impressive!...The company also reported its 1st royalty payment for Vasomax in Mexico........
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext